Reduction of the toxic effects caused by anthraquinone drugs

Details Reduction of the toxic effects caused by anthraquinone drugs Reduction of the toxic effects caused by anthraquinone drugs

1985-08-07

1990-12-25

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

514922, A61K 4900

Patent

active

049801490

ABSTRACT:
The toxic effects caused by anthraquinone drugs, particularly by antitumor anthraquinone drugs, are inhibited or reduced by administering Orgotein in a quantity sufficient to inhibit or reduce the superoxide radicals which are produced by the above mentioned drugs.

REFERENCES:
patent: 4529697 (1985-07-01), Yoshimura et al.
patent: 4548927 (1985-10-01), Eaton
The Merck Index, Tenth Edition, Publ. by Merck & Co., Inc., 1983, p. 6748 (6742).
Young et al., "The Anthracycline Antineoplastic Drugs", The New England Journal of Medicine, vol. 305, pp. 139-153 (1981).
A. M. Michelson et al., "Superoxide and Superoxide Dismutases", by Menender-Huber, pp. 537-549.

Affiliated with

Also associated with

Rating

Reduction of the toxic effects caused by anthraquinone drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of the toxic effects caused by anthraquinone drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of the toxic effects caused by anthraquinone drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1161532